21.70BMarket Cap-66.22P/E (TTM)
25.050High24.000Low3.34MVolume24.300Open24.750Pre Close82.35MTurnover0.38%Turnover Ratio27.54P/E (Static)871.60MShares35.90052wk High3.76P/B21.70BFloat Cap19.80052wk Low--Dividend TTM871.60MShs Float85.800Historical High--Dividend LFY4.24%Amplitude11.360Historical Low24.691Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
HUTCHMED Stock Forum
$Hutchmed (China) (HCM.US)$
$Intra-Cellular Therapies (ITCI.US)$ Phase 3
$CG Oncology (CGON.US)$ Phase 3
$Hutchmed (China) (HCM.US)$ Phase 3
$Viracta Therapeutics (VIRX.US)$ Phase 3
$GlycoMimetics (GLYC.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3
$FibroGen (FGEN.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$Lyra Therapeutics (LYRA.US)$ Phase 3
$Citius Pharmaceuticals (CTXR.US)$ Phase 3
$Marinus Pharmaceuticals (MRNS.US)$ Phase 3
$BioCardia (BCDA.US)$ Phase 3 ...
According to the ac...
No comment yet